Pubblicazioni

Metabolic disorders and gastroenteropancreatic-neuroendocrine tumors (GEP-NETs): How do they influence each other? An Italian Association of Medical Oncology (AIOM)/ Italian Association of Medical Diabetologists (AMD)/ Italian Society of Endocrinology (SIE)/ Italian Society of Pharmacology (SIF) multidisciplinary consensus position paper

2022 - CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Natalicchio, A.; Faggiano, A.; Zatelli, M. C.; Argentiero, A.; D'Oronzo, S.; Marrano, N.; Beretta, G. D.; Acquati, S.; Adinolfi, V.; Di Bartolo, P.; Danesi, R.; Ferrari, P.; Gori, S.; Morviducci, L.; Russo, A.; Tuveri, E.; Montagnani, M.; Gallo, M.; Silvestris, N.; Giorgino, F.

Exocrine pancreatic insufficiency and somatostatin analogs in patients with neuroendocrine neoplasia

2021 - EXPERT OPINION ON DRUG SAFETY

Panzuto, F.; Magi, L.; Rinzivillo, M.

A novel germline mutation at exon 10 of MEN1 gene: a clinical survey and positive genotype-phenotype analysis of a MEN1 Italian family, including monozygotic twins

2018 - HORMONES

Palermo, Andrea; Capoluongo, Ettore; Del Toro, Rossella; Manfrini, Silvia; Pozzilli, Paolo; Maggi, Daria; Defeudis, Giuseppe; Pantano, Francesco; Coppola, Roberto; Di Matteo, Francesco Maria; Raffaelli, Marco; Concolino, Paola; Falchetti, Alberto